Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Higher circulating intermediate monocytes are associated with cognitive function in women with HIV
Rebecca T. Veenhuis, Dionna W. Williams, Erin N. Shirk, Celina M. Abreu, Edna A. Ferreira, Jennifer M. Coughlin, Todd T. Brown, Pauline M. Maki, Kathryn Anastos, Joan W. Berman, Janice E. Clements, Leah H. Rubin
Rebecca T. Veenhuis, Dionna W. Williams, Erin N. Shirk, Celina M. Abreu, Edna A. Ferreira, Jennifer M. Coughlin, Todd T. Brown, Pauline M. Maki, Kathryn Anastos, Joan W. Berman, Janice E. Clements, Leah H. Rubin
View: Text | PDF
Clinical Research and Public Health AIDS/HIV Immunology

Higher circulating intermediate monocytes are associated with cognitive function in women with HIV

  • Text
  • PDF
Abstract

BACKGROUND Identifying a quantitative biomarker of neuropsychiatric dysfunction in people with HIV (PWH) remains a significant challenge in the neuroHIV field. The strongest evidence to date implicates the role of monocytes in central nervous system (CNS) dysfunction in HIV, yet no study has examined monocyte subsets in blood as a correlate and/or predictor of neuropsychiatric function in virally suppressed PWH.METHODS In 2 independent cohorts of virologically suppressed women with HIV (vsWWH; n = 25 and n = 18), whole blood samples were obtained either in conjunction with neuropsychiatric assessments (neuropsychological [NP] test battery, self-report depression and stress-related symptom questionnaires) or 1 year prior to assessments. Immune cell subsets were assessed by flow cytometry.RESULTS A higher proportion of intermediate monocytes (CD14+CD16+) was associated with lower global NP function when assessing monocytes concurrently and approximately 1 year before (predictive) NP testing. The same pattern was seen for executive function (mental flexibility) and processing speed. Conversely, there were no associations with monocyte subsets and depression or stress-related symptoms. Additionally, we found that a higher proportion of classical monocytes was associated with better cognition.CONCLUSION Although it is widely accepted that lentiviral infection of the CNS targets cells of monocyte-macrophage-microglial lineage and is associated with an increase in intermediate monocytes in the blood and monocyte migration into the brain, the percentage of intermediate monocytes in blood of vsWWH has not been associated with neuropsychiatric outcomes. Our findings provide evidence for a new, easily measured, blood-based cognitive biomarker in vsWWH.FUNDING R01-MH113512, R01-MH113512-S, P30-AI094189, R01-MH112391, R01-AI127142, R00-DA044838, U01-AI35004, and P30-MH075673

Authors

Rebecca T. Veenhuis, Dionna W. Williams, Erin N. Shirk, Celina M. Abreu, Edna A. Ferreira, Jennifer M. Coughlin, Todd T. Brown, Pauline M. Maki, Kathryn Anastos, Joan W. Berman, Janice E. Clements, Leah H. Rubin

×

Figure 1

Monocyte subset and MNC calculation for Baltimore cohort.

Options: View larger image (or click on image) Download as PowerPoint
Monocyte subset and MNC calculation for Baltimore cohort.
(A–F) A repres...
(A–F) A representative FACS gating scheme. (A) Doublets were excluded using FSC-A and FSC-H measurements, and (B) debris was gated out by drawing a gate on cell-sized events using FSC-A and SSC-A. (C) TLR2+ cells were gated as monocytes, and nongranulocyte TLR2– cells were gated as lymphocytes. (D) TLR2– lymphocytes were gated as CD3+ T cells or CD159a+ NK cells. (E) CD3+ cells were then gated as CD4+ or CD8+ T cells. (F) TLR2+ monocytes were gated based on the expression of CD14 and CD16 and classified as classical (CD14+CD16–), intermediate (CD14+CD16+), or nonclassical (CD14–CD16+) monocytes. (G) MNCs were counted in the whole blood sample, by summing both TLR2+ monocyte gating, which separates monocytes from granulocytes, and TLR2– lymphocytes as smaller, agranular lymphocytes. Both were gated after debris and doublet removal. TLR2+ monocytes and CD4+ and CD8+ T cell populations were expressed as a percentage of MNCs. Monocyte subsets were expressed as either percentage of TLR2+ or percentage of MNCs.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts